CUSIP 372303206SPONSORED ADSGMABQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
287 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Orbis Allan Gray Ltd | 14.42M | $444.09M | +3.34M | Added |
| 2 | Alliancebernstein L.P. | 10.88M | $335.01M | −76.8K | Reduced |
| 3 | Paradigm Biocapital Advisors LP | 7.04M | $216.83M | +3.22M | Added |
| 4 | Arrowstreet Capital, Limited Partnership | 4.98M | $153.32M |
| +1.33M |
| Added |
| 5 | Blackrock, Inc. | 4.59M | $141.49M | +1.14M | Added |
| 6 | Renaissance Technologies LLC | 3.49M | $107.58M | +671.3K | Added |
| 7 | Harding Loevner LP | 3.37M | $103.85M | −114.3K | Reduced |
| 8 | Morgan Stanley | 1.83M | $56.50M | +159.9K | Added |
| 9 | First Trust Advisors LP | 1.34M | $41.13M | −352.1K | Reduced |
| 10 | Goldman Sachs Group Inc | 1.33M | $41.07M | +214.7K | Added |
See every fund holding Genmab A/S, with full quarter-over-quarter share changes.
Unlock all holders